We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$518M
AUM Growth
-$2.88M
Cap. Flow
-$6.33M
Cap. Flow %
-1.22%
Top 10 Hldgs %
24.95%
Holding
262
New
58
Increased
26
Reduced
109
Closed
58

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$12.6M
2
BAC icon
Bank of America
BAC
+$7.62M
3
TGT icon
Target
TGT
+$6.28M
4
GEN icon
Gen Digital
GEN
+$5.51M
5
TDC icon
Teradata
TDC
+$5.06M

Sector Composition

Rank Sector Weight
1 Financials 18.24%
2 Technology 16.87%
3 Healthcare 10.86%
4 Industrials 9.82%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
151
Cytokinetics
CYTK
$10.4B
$332K 0.06%
34,974
-800
-2% -$7.24K
VER
152
DELISTED
VEREIT, Inc.
VER
$328K 0.06%
+4,685
New +$326K
HA
153
DELISTED
Hawaiian Holdings, Inc.
HA
$326K 0.06%
23,358
-500
-2% -$5.84K
ECPG icon
154
Encore Capital Group
ECPG
$2.13B
$319K 0.06%
6,988
-100
-1% -$4.83K
EBIX
155
DELISTED
Ebix Inc
EBIX
$318K 0.06%
18,618
-500
-3% -$7.71K
MTOR
156
DELISTED
MERITOR, Inc.
MTOR
$313K 0.06%
25,541
-400
-2% -$4.5K
GSM icon
157
FerroAtlántica
GSM
$839M
$303K 0.06%
14,552
-300
-2% -$5.7K
SJM icon
158
J.M. Smucker
SJM
$12.8B
$298K 0.06%
3,069
UNIS
159
DELISTED
Unilife Corporation
UNIS
$294K 0.06%
7,216
-50
-0.7% -$2.26K
IDTI
160
DELISTED
Integrated Device Technology I
IDTI
$293K 0.06%
23,980
-63,507
-73% -$719K
STML
161
DELISTED
Stemline Therapeutics, Inc.
STML
$292K 0.06%
14,345
-8,488
-37% -$206K
MDGL icon
162
Madrigal Pharmaceuticals
MDGL
$11.8B
$286K 0.06%
+1,897
New +$374K
GTS
163
DELISTED
Triple-S Management Corporation
GTS
$283K 0.05%
18,455
-24,436
-57% -$407K
QCOR
164
DELISTED
QUESTCOR PHARMA INC
QCOR
$275K 0.05%
4,235
-3,911
-48% -$250K
OZK icon
165
Bank OZK
OZK
$5.61B
$272K 0.05%
+8,000
New +$249K
ARGS
166
DELISTED
Argos Therapeutics, Inc.
ARGS
$267K 0.05%
+1,336
New +$267K
TGI
167
DELISTED
Triumph Group
TGI
$266K 0.05%
4,117
-100
-2% -$6.84K
EXXI
168
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$265K 0.05%
11,239
-500
-4% -$11.8K
MON
169
DELISTED
Monsanto Co
MON
$257K 0.05%
+2,260
New +$252K
NAVB
170
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$255K 0.05%
6,901
-225
-3% -$8.53K
AMZN icon
171
Amazon
AMZN
$2.96T
$252K 0.05%
+15,000
New +$278K
HOMB icon
172
Home BancShares
HOMB
$6.18B
$247K 0.05%
+14,326
New +$241K
LMT icon
173
Lockheed Martin
LMT
$136B
$245K 0.05%
1,500
CB
174
DELISTED
CHUBB CORPORATION
CB
$245K 0.05%
2,745
NSM
175
DELISTED
Nationstar Mortgage Holdings
NSM
$244K 0.05%
+7,531
New +$232K

Similar funds

Stoneridge Investment Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Stoneridge Investment Partners held 262 positions worth $518M, down 0.55% from $521M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Stoneridge Investment Partners's Q1 2014 filing shows 58 new, 26 increased, 109 reduced and 58 closed positions. Its largest new stake was PHARMACYCLICS INC: 96,553 shares worth $9.68M. The largest sale was Mondelez International, an estimated $10.1M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Stoneridge Investment Partners's largest Q1 2014 buy was PHARMACYCLICS INC: 96,553 shares worth $9.68M.
  • Stoneridge Investment Partners added most to Target in Q1 2014, an estimated $6.28M increase.
  • Stoneridge Investment Partners's biggest Q1 2014 reduction was Cisco, cutting an estimated $7M.
  • Stoneridge Investment Partners fully exited Mondelez International in Q1 2014, selling an estimated $10.1M.
  • Stoneridge Investment Partners's ten largest holdings make up 25% of its $518M portfolio in Q1 2014.
  • Stoneridge Investment Partners opened 58 new positions and closed 58 in Q1 2014.
  • Stoneridge Investment Partners's portfolio value fell 0.55% quarter-over-quarter to $518M.

Based on Stoneridge Investment Partners's 13F filing for Q1 2014, filed 15 Apr 2014.